Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery.
Abstract
No abstract available
Citations
Altmetric:
Date
2022-04-28
Type
Article
Subject
Biochemistry, Diseases & disorders of systemic, metabolic or environmental origin
Collections
Citation
Sharma M, Nayar R, Graham Y, Parretti HM, Abbott S, Tahrani A, Miras AD, Madhok B, Singhal R, Mahawar K. Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery. Obes Surg. 2022 Jul;32(7):2469-2470. doi: 10.1007/s11695-022-06044-6. Epub 2022 Apr 28
Journal / Source Title
Obesity Surgery
DOI
10.1007/s11695-022-06044-6
PMID
35482224
Publisher
Springer
Publisher’s URL
https://link.springer.com/journal/11695